Skip to content

Combination with Sevoflurane Anesthesia Attenuates Nasopharyngeal Secretions in Propofol-Based Total Intravenous Anesthesia in Ocular Surgery

Combination with Sevoflurane Anesthesia Attenuates Nasopharyngeal Secretions in Propofol-Based Total Intravenous Anesthesia in Ocular Surgery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12616001120460
Enrollment
50
Registered
2016-08-17
Start date
2015-10-29
Completion date
2016-03-15
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Background: About 10% patients under general anesthesia had nasopharyngeal secretions on the face at the end of ocular surgery, and secretions toward the eye in some patients. It may induce postoperative endophthalmitis, although rare, still of great concern to the ophthalmologist. Therefore, anesthetics that produce less nasopharyngeal secretions are desirable. Nasopharyngeal excretion under propofol-based total intravanous anesthesia (TIVA) is greater than sevoflurane anesthesia during surgery. However, postoperative nausea and vomiting (PONV) after inhalational anesthesia is higher than TIVA and may increase intraocluar pressure. As our best knlowldge, no previous report discussed the nasopharyngeal secretions and PONV while sevoflurane combines with propofol anesthesia. Therefore, the aim of this study is to investigate the effect of sevoflurane combination with propofol-based TIVA on nasopharyngeal secrtions and PONV in ocular surgery. Methods: Fifty patients undergoing ocular surgery were randomly assigned for propofol-based TIVA or propofol/sevoflurane anesthesia. In the TIVA group patients (n = 25), anesthesia was induced and maintained with propofol and i.v. fentanyl, whereas, in the propofol/sevoflurane group patients (n = 25), 1% sevoflurane anesthesia was added. All patient were moniotored under bispectral index (BIS). We prospectively compared the nasopharyngeal secretion volume, extubation time and incidence of PONV after the procedure in both groups.

Interventions

In the propofol/sevoflurane group, the anesthesia induction were as the total intravenous anaesthesia (TIVA) group patients, whereas anesthesia was maintained using intravenous propofol infusion and 1% sevoflurane (inhaled concentration) with with 50% oxygen flow of 1 mL/min by the treating anaesthetist. Maintenance of the effect-site concentration (Ce) for the propofol/sevoflurane was adjusted to keep BIS value between 40–60 and mean arterial blood pressure at 80–100 mm Hg determined by the t

In the propofol/sevoflurane group, the anesthesia induction were as the total intravenous anaesthesia (TIVA) group patients, whereas anesthesia was maintained using intravenous propofol infusion and 1% sevoflurane (inhaled concentration) with with 50% oxygen flow of 1 mL/min by the treating anaesthetist. Maintenance of the effect-site concentration (Ce) for the propofol/sevoflurane was adjusted to keep BIS value between 40–60 and mean arterial blood pressure at 80–100 mm Hg determined by the treating anaesthetist. The EtCO2 pressure was maintained at 35-45 mmHg. Once neuromuscular function returns, rocuronium (0.1 mg/kg, intravenously [i.v.]) was administered as required by the treating anaesthetist. All patients received i.v. methasone 0.1 mg/kg for preventing post-operative nausea and vomiting (PONV) while induction of anaesthesia by the treating anaesthetist.. At the end of the procedure, propofol or sevoflurane was discontinued and the lungs were ventilated with 100% oxygen at a fresh gas flow of 6 L/min by the treating anaesthetist. Reversal of neuromuscular function was achieved by administrating neostigmine (0.03-0.04 mg/kg, i.v.) with glycopyrrolate (0.006-0.008 mg/kg, i.v.) once spontaneous breathing returned to prevent residual paralysis at the clinical discretion of the treating anaesthetist. When the patient regained consciousness by name with spontaneous and smooth respiration, the endotracheal tube was removed and the patient was sent to the postoperative anesthesis care unit for further care.

Sponsors

Tri-Service General Hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Subject, Caregiver)

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

50 patients scheduled to undergo ocular surgery by one ophthalmologist under GA were enrolled in this study

Exclusion criteria

(1) age < 20 years or older than 80 years, (2) American Society of Anesthesiologists (ASA) physical status of more than III, (3) body mass index (BMI) > 30 kg/m2, (4) possible pregnancy, (5) emergent surgeries, (6) uremia, and (7) liver disease.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026